Placental Histotherapy is the study of the human placenta and its usefulness in developing medication that can be effective in the treatment of such conditions as Vitiligo, Psoriasis and Alopecia pioneered by Dr. Carlos Miyares Cao a world renown researcher, has a doctorate in Medicine from the University of Havana, Cuba specializing in Gynecology, Obstetrics and Pharmacology and from 1965 to 1975 was professor of Pharmacology at the University of Havana, Cuba. He is also a Senior Researcher and has directed approximately 100 research studies.
In the 1970’s, Dr. Carlos Miyares Cao studying the metabolism of the placenta detected a substance that triggers the production of melanocytes, pigments responsible for color in skin, hair and eyes. Due to this discovery, Cuba has discontinued its exportation of human placenta in order to use it in creating new drugs and cosmetics. To this day, twenty new products have been developed including Melagenina Plus for the treatment of Vitiligo, Cordemina for the treatment of Psoriasis and Piloactive Lotion and the Piloactive Shampoo for the treatment different types of Alopecia.
In 1985 Cira García Clinic was established in Havana under the supervision of Dr. Carlos Miyares Cao. The success of the clinic locally and internationally propelled the Cuban government in 1986 to establish the Placental Histotherapy Center with Dr. Carlos Miyares Cao as its director. In 1987, the International and National Clinical Service was established due to high demand and increased number of foreign patients seeking treatment in Cuba (100 patients a month from 90 different countries).
From 1988 to 1991 medical centers were set up in other countries. The staff of these centers gained their training at the Placental Histotherapy Center so as to ensure the same efficiency in the application of the method used in Cuba.
The method developed by Dr. Carlos Miyares Cao is registered in Cuba, Japan, India, Hungary, England, Russia, Germany, USA, France and Sweden.